Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects

The psychedelic psilocybin is being investigated for the treatment of depression and anxiety. Unclear is whether antidepressant treatments interact with psilocybin. The present study used a double‐blind, placebo‐controlled, crossover design with two experimental test sessions to investigate the resp...

Full description

Bibliographic Details

Published in:	Clinical pharmacology and therapeutics Vol. 111; no. 4; pp. 886 - 895
Main Authors:	Becker, Anna M., Holze, Friederike, Grandinetti, Tanja, Klaiber, Aaron, Toedtli, Vanja E., Kolaczynska, Karolina E., Duthaler, Urs, Varghese, Nimmy, Eckert, Anne, Grünblatt, Edna, Liechti, Matthias E.
Format:	Journal Article
Language:	English
Published:	United States 01.04.2022
Subjects:	Antidepressive Agents - adverse effects Brain-Derived Neurotrophic Factor - genetics Citalopram - adverse effects Cross-Over Studies Double-Blind Method Escitalopram Healthy Volunteers Humans Psilocybin - adverse effects
ISSN:	0009-9236, 1532-6535, 1532-6535
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!